+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032- Product Image
Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134352
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pneumococcal Polysaccharide Vaccine Market is projected to reach USD 3.06 Billion in 2026. It is expected to continue growing at a CAGR of 9.59%, reaching USD 5.30 Billion by 2032.

Pneumococcal Polysaccharide Vaccines: Executive Overview

Pneumococcal polysaccharide vaccines help protect against invasive disease caused by selected serotypes of Streptococcus pneumoniae. Their public-health relevance is linked to severe outcomes such as pneumonia, meningitis, and bloodstream infection, particularly among older adults, people with chronic conditions, and individuals with weakened immunity. Policy decisions increasingly consider polysaccharide vaccines alongside conjugate products, local epidemiology, product indications, and national immunization guidance.

Policy and Delivery Shifts Reshaping Pneumococcal Prevention

The landscape is shifting from product-centered decisions toward life-course immunization strategies. Authorities are refining recommendations by age, risk status, prior vaccination, and available vaccine formulations, while health systems are integrating adult vaccination into primary care, pharmacies, hospitals, and chronic-disease services. Persistent barriers include missed appointments, uneven access, differences in reimbursement, cold-chain requirements, and the need for clearer communication about revaccination and sequential schedules.

How Artificial Intelligence Can Improve Pneumococcal Immunization

Artificial intelligence can support pneumococcal prevention by identifying people who may be eligible from electronic health records, predicting missed vaccinations, and prioritizing outreach to high-risk populations. Natural-language tools can assist clinicians in interpreting complex vaccination histories, while analytics can help programs monitor uptake, safety signals, and geographic gaps. Responsible use requires validated data, transparent clinical oversight, privacy safeguards, and controls against unequal performance across age, ethnicity, socioeconomic status, and health-system settings.

Regional Insights Across Pneumococcal Vaccine Programs

North America generally benefits from established adult-immunization infrastructure, but uptake still depends on provider recommendation, insurance coverage, and coordinated records. Europe combines mature surveillance with varied national schedules, procurement systems, and reimbursement rules. Asia-Pacific spans highly diverse epidemiology and delivery capacity, making integration with primary care and older-adult services important. Latin America continues to balance public-sector access, fiscal constraints, and uneven surveillance. The Middle East shows differing levels of national-program maturity and private-sector participation, while Africa faces substantial burdens from infectious disease, limited health-system capacity, and the need to strengthen routine and adult vaccination platforms.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members face diverse financing, surveillance, and delivery environments, creating a need for interoperable guidance and stronger regional procurement coordination. BRICS countries encompass large and heterogeneous populations, so national strategies must address urban-rural disparities and varying adult-immunization capacity. European Union members benefit from shared technical collaboration but retain distinct schedules and reimbursement policies. G7 systems can advance evidence-based adult vaccination, digital registries, and post-market monitoring. GCC countries often have comparatively concentrated health infrastructure and substantial expatriate populations, requiring inclusive access policies. NATO members can incorporate pneumococcal prevention into health-resilience planning, particularly for vulnerable populations and continuity of care.

Country Insights: Diverse National Approaches to Pneumococcal Prevention

Australia uses national immunization guidance and risk-based recommendations to support protection of older adults and medically vulnerable groups. Brazil and Mexico must address regional inequality and differences between public and private delivery. Canada and the United States rely on mature clinical guidance, yet access, documentation, and provider engagement remain important. China and India face substantial population diversity and varied regional health-system capacity, emphasizing surveillance and scalable primary care. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom continue to refine adult and risk-based vaccination pathways within established health systems. Russia’s priorities include maintaining access across geographically dispersed populations and strengthening consistent program delivery.

Actions for Leaders to Strengthen Pneumococcal Vaccine Programs

Industry leaders should align evidence generation with national policy questions, including comparative use of vaccine types, sequencing, durability, and protection in high-risk groups. They should simplify eligibility and scheduling messages, support interoperable vaccination records, and work with providers to embed recommendations in routine encounters. Operational priorities include resilient supply planning, temperature-control assurance, pharmacovigilance, and equitable access models. Partnerships with public-health agencies should focus on transparent education, real-world outcomes, and measurable improvements in coverage rather than promotion alone.

Methodology for Assessing the Pneumococcal Polysaccharide Vaccine Landscape

This executive summary uses a structured secondary-research framework focused on authoritative immunization recommendations, public-health surveillance, regulatory information, peer-reviewed clinical evidence, and health-system implementation literature. Findings are synthesized by geography and multilateral group, with attention to disease burden, eligibility guidance, delivery infrastructure, access conditions, and emerging digital capabilities. Because the available reference identifies the market category but provides no quantitative dataset, the assessment intentionally excludes market estimates, market sizing, shares, and forecasts.

Conclusion: Building More Equitable Pneumococcal Protection

Pneumococcal polysaccharide vaccination remains relevant within broader, evidence-based strategies for preventing serious pneumococcal disease. Progress will depend less on product availability alone than on accurate risk identification, consistent recommendations, accessible delivery, reliable records, and sustained public confidence. Regional and country differences require adaptable implementation, while artificial intelligence can add value only when deployed with strong governance, clinical accountability, and equity safeguards.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pneumococcal Polysaccharide Vaccine Market, by Age Group
7.1. Introduction
7.2. Adults 18-64
7.2.1. 18-44
7.2.2. 45-64
7.3. Elderly 65+
7.3.1. 65-74
7.3.2. 75+
7.4. Pediatrics 0-17
7.4.1. 0-2
7.4.2. 13-17
7.4.3. 3-12
8. Pneumococcal Polysaccharide Vaccine Market, by Administration Route
8.1. Introduction
8.2. Intramuscular
8.3. Subcutaneous
9. Pneumococcal Polysaccharide Vaccine Market, by Presentation
9.1. Introduction
9.2. Pre-Filled Syringes
9.3. Vials
9.3.1. Multi-Dose Vials
9.3.2. Single-Dose Vials
10. Pneumococcal Polysaccharide Vaccine Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Government Clinics
10.3.2. Private Clinics
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Pneumococcal Polysaccharide Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Pneumococcal Polysaccharide Vaccine Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Pneumococcal Polysaccharide Vaccine Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Pneumococcal Polysaccharide Vaccine Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott
16.2. Biological E. Limited
16.3. Cadila Healthcare
16.4. Emergent BioSolutions
16.5. GC Biopharma Corp.
16.6. GlaxoSmithKline
16.7. Merck & Co.
16.8. Panacea Biotec Ltd.
16.9. Pfizer Inc.
16.10. Sanofi
16.11. Seqirus
16.12. Serum Institute of India
16.13. Takeda
16.14. Walvax Biotechnology
16.15. Xiamen Innovax Biotech Co. Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pneumococcal Polysaccharide Vaccine Market, Years Considered for the Study
FIGURE 2. Global Pneumococcal Polysaccharide Vaccine Market, Research Design
FIGURE 3. Global Pneumococcal Polysaccharide Vaccine Market, Research Framework
FIGURE 4. Global Pneumococcal Polysaccharide Vaccine Market, Data Triangulation
FIGURE 5. Global Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 7. Global Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 9. Global Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2025 vs 2032 (%)
FIGURE 11. Global Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Pneumococcal Polysaccharide Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Pneumococcal Polysaccharide Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Pneumococcal Polysaccharide Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pneumococcal Polysaccharide Vaccine Market Segmentation & Coverage
TABLE 2. Global Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 4. Global Adults 18-64 Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Adults 18-64 Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Adults 18-64 Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 18-44 Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 18-44 Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 18-44 Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 45-64 Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 45-64 Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 45-64 Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Elderly 65+ Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Elderly 65+ Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Elderly 65+ Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 65-74 Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global 65-74 Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global 65-74 Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global 75+ Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global 75+ Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global 75+ Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Pediatrics 0-17 Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Pediatrics 0-17 Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Pediatrics 0-17 Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global 0-2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global 0-2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global 0-2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global 13-17 Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global 13-17 Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global 13-17 Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global 3-12 Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global 3-12 Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global 3-12 Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 35. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 42. Global Pre-Filled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Pre-Filled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Pre-Filled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Multi-Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Multi-Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Multi-Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Single-Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Single-Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Single-Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Government Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Government Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Government Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Private Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Private Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Private Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. North America Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 101. North America Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 102. North America Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 103. North America Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 104. North America Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 105. North America Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 106. North America Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 107. North America Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. North America Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 109. North America Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 110. North America Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 113. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 114. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 115. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 116. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 117. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 118. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 119. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 121. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 122. Latin America Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 125. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 126. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 127. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 128. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 129. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 130. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 131. Europe Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 133. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 134. Europe Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 137. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 138. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 139. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 140. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 141. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 142. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 143. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 145. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 146. Middle East Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 149. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 150. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 151. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 152. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 153. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 154. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 155. Africa Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 157. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 158. Africa Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. Global Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 162. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 163. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 164. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 165. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 166. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 167. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 168. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 170. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 171. ASEAN Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 174. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 175. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 176. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 177. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 178. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 179. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 180. GCC Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 182. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. GCC Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 186. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 187. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 188. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 189. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 190. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 191. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 192. European Union Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 194. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 195. European Union Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 198. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 199. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 200. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 201. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 202. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 203. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 204. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 206. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 207. BRICS Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 210. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 211. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 212. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 213. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 214. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 215. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 216. G7 Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 218. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 219. G7 Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 222. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 223. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 224. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 225. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 226. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 227. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 228. NATO Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 230. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. NATO Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Global Pneumococcal Polysaccharide Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. United States Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 234. United States Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 235. United States Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 236. United States Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 237. United States Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 238. United States Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 239. United States Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 240. United States Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 241. United States Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. United States Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 243. United States Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 244. United States Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. Canada Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 246. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 247. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 248. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 249. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 250. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 251. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 252. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 253. Canada Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 255. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 256. Canada Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. Mexico Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 258. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 259. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 260. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 261. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 262. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 263. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 264. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 265. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 267. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 268. Mexico Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Brazil Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 270. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 271. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 272. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 273. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 274. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 275. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 276. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 277. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 279. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 280. Brazil Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 281. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 282. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 283. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 284. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 285. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 286. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 287. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 288. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 289. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 291. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 292. United Kingdom Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. Germany Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 294. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 295. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 296. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 297. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 298. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 299. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 300. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 301. Germany Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 303. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 304. Germany Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 305. France Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 306. France Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 307. France Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 308. France Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 309. France Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 310. France Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 311. France Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 312. France Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 313. France Pneumococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. France Pneumococcal Polysaccharide Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 315. France Pneumococcal Polysaccharide Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 316. France Pneumococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. Russia Pneumococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 318. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 319. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Adults 18-64, 2017-2032 (USD Million)
TABLE 320. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Elderly 65+, 2017-2032 (USD Million)
TABLE 321. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Pediatrics 0-17, 2017-2032 (USD Million)
TABLE 322. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 323. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 324. Russia Pneumococcal Polysaccharide Vaccine Market Size, by Vials, 2017-2032 (USD Million)
TABLE 325. Russia Pneumoco

Companies Mentioned

  • Abbott
  • Biological E. Limited
  • Cadila Healthcare
  • Emergent BioSolutions
  • GC Biopharma Corp.
  • GlaxoSmithKline
  • Merck & Co.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi
  • Seqirus
  • Serum Institute of India
  • Takeda
  • Walvax Biotechnology
  • Xiamen Innovax Biotech Co. Ltd.

Related Topics

Related Reports

23-Valent Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032 - Product Image

23-Valent Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Prevent Meningitis Vaccine Market - Global Forecast 2026-2032 - Product Image

Prevent Meningitis Vaccine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Pneumococcal Vaccine Market Size, Share, Trends and Forecast by Vaccine Type, Product Type, Distribution Channel, End User, and Region, 2026-2034 - Product Image

Pneumococcal Vaccine Market Size, Share, Trends and Forecast by Vaccine Type, Product Type, Distribution Channel, End User, and Region, 2026-2034

  • Report
  • 135 Pages
  • Global
From
Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 160 Pages
  • Global
From
Pneumovax 23 Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Pneumovax 23 Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From

About the Market

The Pneumococcal Polysaccharide Vaccine (PPV) is a vaccine used to protect against infections caused by the bacterium Streptococcus pneumoniae. It is recommended for adults over the age of 65, as well as those with certain medical conditions, such as asthma, diabetes, and heart disease. The vaccine is administered as a single injection, and is usually given in combination with other vaccines. It is also recommended for children aged 2-5 years, and for those who are at high risk of developing pneumococcal disease. PPV is a widely used vaccine, and is available in many countries around the world. It is typically administered in combination with other vaccines, such as the influenza vaccine, and is often given in combination with other vaccines in a single injection. The PPV market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.